AN2 Therapeutics, Inc. (ANTX)

4.55 +0.07 (+1.56%) USD  |  NASDAQ  |  May 19, 16:00
4.50 -0.05 (-1.10%) After-Hours: 20:00
More

AN2 Therapeutics Revenue Estimates for Current Fiscal Year

Revenue Estimates for Current Fiscal Year Chart

View Revenue Estimates for Current Fiscal Year for ANTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Current Fiscal Year Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Revenue Estimates for Current Fiscal Year Range, Past 5 Years

View Revenue Estimates for Current Fiscal Year Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Current Fiscal Year Benchmarks

View Revenue Estimates for Current Fiscal Year Benchmarks
Start Trial
Relmada Therapeutics, Inc. Upgrade
Corcept Therapeutics, Inc. Upgrade
Assertio Holdings, Inc. Upgrade
Johnson & Johnson Upgrade
Eli Lilly & Co. Upgrade

Revenue Estimates for Current Fiscal Year Related Metrics

EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade